Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP759990.RAZPywnfuxzznzE9C_UfPXVXJWKUjYn-TX4rkqUlqYaBA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP759990.RAZPywnfuxzznzE9C_UfPXVXJWKUjYn-TX4rkqUlqYaBA130_assertion type Assertion NP759990.RAZPywnfuxzznzE9C_UfPXVXJWKUjYn-TX4rkqUlqYaBA130_head.
- NP759990.RAZPywnfuxzznzE9C_UfPXVXJWKUjYn-TX4rkqUlqYaBA130_assertion description "[XPD Lys751Gln polymorphism may be an important marker in the prediction of clinical outcome to chemo-radiotherapy in resected gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP759990.RAZPywnfuxzznzE9C_UfPXVXJWKUjYn-TX4rkqUlqYaBA130_provenance.
- NP759990.RAZPywnfuxzznzE9C_UfPXVXJWKUjYn-TX4rkqUlqYaBA130_assertion evidence source_evidence_literature NP759990.RAZPywnfuxzznzE9C_UfPXVXJWKUjYn-TX4rkqUlqYaBA130_provenance.
- NP759990.RAZPywnfuxzznzE9C_UfPXVXJWKUjYn-TX4rkqUlqYaBA130_assertion SIO_000772 17009404 NP759990.RAZPywnfuxzznzE9C_UfPXVXJWKUjYn-TX4rkqUlqYaBA130_provenance.
- NP759990.RAZPywnfuxzznzE9C_UfPXVXJWKUjYn-TX4rkqUlqYaBA130_assertion wasDerivedFrom befree-20140225 NP759990.RAZPywnfuxzznzE9C_UfPXVXJWKUjYn-TX4rkqUlqYaBA130_provenance.
- NP759990.RAZPywnfuxzznzE9C_UfPXVXJWKUjYn-TX4rkqUlqYaBA130_assertion wasGeneratedBy ECO_0000203 NP759990.RAZPywnfuxzznzE9C_UfPXVXJWKUjYn-TX4rkqUlqYaBA130_provenance.